CLC Number:
| [1] Sarin SK, Choudhury A, Sharma MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver(APASL): an update[J]. Hepatol Int, 2019, 13(4):353-390. [2] Arroyo V, Moreau R, Jalan R. Acute-on-chronic liver failure[J]. N Engl J Med, 2020, 382(22):2137-2145. [3] Wu T, Li J, Shao L, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure[J]. Gut, 2018, 67(12):2181-2191. [4] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版)[J].西南医科大学学报,2019,42(2):99-106. Liver Failure and Artificial Liver Group,Chinese Society of Infectious Diseases,Chinese Medical Association;Severe Liver Disease and Artificial Liver Group,Chinese Society of Hepatology,Chinese Medical Association. Guideline for diagnosis and Treatment of Liver Failure(2018)[J]. Journal of Southwest Medical University,2019,42(2):99-106. [5] Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world[J]. J Hepatol, 2019, 70(1):151-171. [6] Kitajima Y, Takahashi H, Akiyama T, et al. Supplementation with branched-chain amino acids ameliorates hypoalbuminemia, prevents sarcopenia, and reduces fat accumulation in the skeletal muscles of patients with liver cirrhosis[J]. J Gastroenterol, 2018, 53(3):427-437. [7] Sarin SK, Choudhury A. Acute-on-chronic liver failure: terminology, mechanisms and management[J]. Nat Rev Gastroenterol Hepatol, 2016, 13(3):131-149. [8] SunL J, Yu JW, Zhao YH, et al. Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure[J]. J Gastroenterol Hepatol, 2010, 25(3):583-590. [9] Nyberg SL. Bridging the gap: advances in artificial liver support[J]. Liver Transpl, 2012, 18 Suppl 2:S10-4. doi: 10.1002/lt.23506. [10] Gelfand JM, Wan J, Zhang H, et al. Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: a population-based study[J]. J Am Acad Dermatol, 2021, 84(6):1636-1643. [11] Lagha IB, Jaber K, Rabhi F, et al. Psoriasis and liver fibrosis: an investigation using transient elastography in Tunisian patients with psoriasis[J]. Br J Dermatol, 2019, 181(6):1306-1308. [12] Maybury CM. Porter HF, Kloczko E, et al. Prevalence of advanced liver fibrosis in patients with severe psoriasis[J]. JAMA Dermatol, 2019, 155(9):1028-1032. [13] Pongpit J, Porntharukchareon S, Kaewduang P, et al. Liver stiffness measurement in psoriasis: do metabolic or disease factors play the important role?[J]. Biomed Res Int, 2016, 2016:7963972. doi: 10.1155/2016/7963972. [14] Triantafyllou E, Woollard KJ, McPhail MJW, et al. The role of monocytes and macrophages in acute and acute-on-chronic liver failure[J]. Front Immunol, 2018, 9:2948. doi:10.3389/fimmu.2018.02948. [15] Xue R, Meng Q. The management of glucocorticoid therapy in liver failure[J]. Front Immunol, 2019, 10:2490. doi: 10.3389/fimmu.2019.02490. [16] Verma N, Singh S,Taneja S, et al. Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections[J]. Liver Int, 2019, 39(3):503-513. [17] Lahmer T, Pecanha-Pietrobom PM, Schmid RM, et al. Invasive fungal infections in acute and chronic liver impairment: a systematic review[J]. Mycoses, 2022, 65(2):140-151. [18] Roy A, Verma N, Ahuja CK. Intracranial invasive mycosis mimicking hepatic encephalopathy in a patient with cirrhosis[J]. BMJ Case Rep, 2019, 12(11):e231548. doi: 10.1136/bcr-2019-231548. [19] Sulik-Tyszka B, Figiel W, Krawczyk M, et al. Invasive aspergillosis of the stomach and co-infection with candida krusei in a patient with terminal liver failure: a case report[J]. Transplant Proc, 2016, 48(9):3149-3152. [20] Lamoth F, Alexander BD. Nonmolecular methods for the diagnosis of respiratory fungal infections[J]. Clin Lab Med, 2014, 34(2):315-336. [21] Lin LN, Zhu Y, Che FB, et al. Invasive fungal infections secondary to acute-on-chronic liver failure: a retrospective study[J]. Mycoses, 2013, 56(4):429-433. [22] Vena A, Bouza E, Bassetti M, et al. Comparison of the safety and tolerance profile of micafungin with that of other echinocandins and azoles in patients with pre-existing child-pugh B or C liver disease: a case-control retrospective study[J]. Infect Dis Ther, 2020, 9(1):151-163. [23] Luque S, Campillo N, Alvarez-Lerma F, et al. Pharmacokinetics of micafungin in patients with pre-existing liver dysfunction: a safe option for treating invasive fungal infections[J]. Enferm Infecc Microbiol Clin, 2016, 34(10):652-654. |
| [1] | FAN Gui-ling1， YAO Yong2， YAO Li3, JIA Chong-qi4. Association between Arg47His mutation in the ADH2 gene and chronic hepatitis B [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(11): 101-104. |
| [2] | YE Qing1, RONG Lin2, WANG Xin-ting3, SHAO Li-hua2. Protein nitrotyrosine and cell apoptosis in the liver and brain of hepatic encephalopathy rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(8): 38-41. |
| [3] | RONG Lin1, SHAO Lihua1,CHI Defeng1, WANG Shue1, WANG Xifeng1, WANG Xinting2, MA Lixian3. Inhibitory effects of ebselen on hepatic encephalopathy of rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(5): 154-. |
| [4] | ZHAO Xiu-hua,ZHANG Jing-yao,SONY Xiu-guang,WANG Xiao-hua,SHAO Fei,CHEN Shi-jun. Effect of MARS on severe hepatitis and its related factors [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(2): 217-220. |
| [5] | JIAO Qinghua, ZHOU Qingbo, WANG Yan, XU Min, CHEN Huiling, WEN Jie. Tumor-specific survival advantage in young patients with stage Ⅲ small cell lung cancer [J]. Journal of Shandong University (Health Sciences), 2019, 57(12): 68-73. |
| [6] | ZHANG Zong, WANG Xiaohua. Advances in the diagnosis and treatment of hepatic encephalopathy [J]. Journal of Shandong University (Health Sciences), 2018, 56(2): 1-8. |
|
